Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial.

Authors
Type
Published Article
Journal
BMC Gastroenterology
1471-230X
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Volume
10
Pages
21–21
Identifiers
DOI: 10.1186/1471-230X-10-21
PMID: 20170514
Source
Medline

Abstract

Statistics

Seen <100 times